Search Prime Grants

W81XWH2110639

Project Grant

Overview

Grant Description
Covid-19 novel pharmacological interventions for ARDS of Covid-19 patients: Investigational new drug-enabling studies.
Awardee
University Of Illinois
Funding Goals
PEER REVIEWED MEDICAL RESEARCH PROGRAM AWARD MECHANISM: TECHNOLOGY/THERAPEUTIC DEVELOPMENT AWARD
Grant Program (CFDA)
12.420 - Military Medical Research and Development
Awarding / Funding Agency
Defense Health Agency (DHA) [DoD]
Place of Performance
Chicago, Illinois 606124305 United States
Geographic Scope
Single Zip Code
Related Opportunity
W81XWH20PRMRPTTDACOV
Analysis Notes
Amendment Since initial award the End Date has been extended from 07/14/24 to 07/14/26.
University Of Illinois was awarded Covid-19 ARDS Pharmacological Interventions: INDE Studies Project Grant W81XWH2110639 worth $5,860,641 from Defense Health Agency in July 2021 with work to be completed primarily in Chicago Illinois United States. The grant has a duration of 5 years and was awarded through assistance program 12.420 Military Medical Research and Development.

Status
(Ongoing)

Last Modified 7/31/25

Period of Performance
7/15/21
Start Date
7/14/26
End Date
82.0% Complete

Funding Split
$5.9M
Federal Obligation
$0.0
Non-Federal Obligation
$5.9M
Total Obligated
100.0% Federal Funding
0.0% Non-Federal Funding

Activity Timeline

Interactive chart of timeline of amendments to W81XWH2110639

Subgrant Awards

Disclosed subgrants for W81XWH2110639

Transaction History

Modifications to W81XWH2110639

Additional Detail

Award ID FAIN
W81XWH2110639
SAI Number
None
Award ID URI
None
Awardee Classifications
Public/State Controlled Institution Of Higher Education
State Government
Awarding Office
HT9425 ARMY MED RES ACQ ACTIVITY
Funding Office
HT0989 CONG DIR MED RES PRGM / CDMRP - MM
Awardee UEI
W8XEAJDKMXH3
Awardee CAGE
1YGW1
Performance District
IL-07
Senators
Richard Durbin
Tammy Duckworth
Modified: 7/31/25